Literature DB >> 15796769

The human MT1 melatonin receptor stimulates cAMP production in the human neuroblastoma cell line SH-SY5Y cells via a calcium-calmodulin signal transduction pathway.

C Schuster1, L M Williams, A Morris, P J Morgan, P Barrett.   

Abstract

Melatonin regulates circadian and seasonal physiology via melatonin receptors expressed in the brain. However, little is known about the signal transduction mechanisms that mediate the action of melatonin in neuronal cells. To begin to address this issue, we expressed the human MT(1) receptor in the human neuroblastoma SH-SY5Y cell line. In this cell line, melatonin acutely stimulated cAMP synthesis through a calcium-calmodulin dependent pathway. This stimulatory effect was independent of an interaction with G(i) or G(s) G proteins and dependent upon internal calcium stores. Melatonin also potentiated forskolin-activated cAMP synthesis. Differentiation of the neuroblastoma cells with retinoic acid to the neuronal phenotype did not alter the ability of melatonin to acutely stimulate cAMP. These data may be relevant to the neuronal action of melatonin and highlight the importance of the cellular context of expression of melatonin and other G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796769     DOI: 10.1111/j.1365-2826.2005.01288.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  12 in total

Review 1.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

2.  Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures.

Authors:  Nereida Valero; Luz Marina Espina; Jesus Mosquera
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

3.  Melatonin modulates the expression of BCL-xl and improve the development of vitrified embryos obtained by IVF in mice.

Authors:  Maryam Dehghani-Mohammadabadi; Mohammad Salehi; Fattaneh Farifteh; Sedigheh Nematollahi; Ehsan Arefian; Atena Hajjarizadeh; Kazem Parivar; Zahra Nourmohammadi
Journal:  J Assist Reprod Genet       Date:  2014-01-14       Impact factor: 3.412

4.  Pterostilbene attenuates amyloid-β induced neurotoxicity with regulating PDE4A-CREB-BDNF pathway.

Authors:  Jiao Meng; Yuhua Chen; Fangfang Bi; Hua Li; Cuicui Chang; Wei Liu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 5.  Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.

Authors:  Stephen G Grant; Melissa A Melan; Jean J Latimer; Paula A Witt-Enderby
Journal:  Expert Rev Mol Med       Date:  2009-02-05       Impact factor: 5.600

Review 6.  Melatonin in Alzheimer's disease.

Authors:  Li Lin; Qiong-Xia Huang; Shu-Sheng Yang; Jiang Chu; Jian-Zhi Wang; Qing Tian
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

Review 7.  Melatonin and cancer.

Authors:  A A Zamfir Chiru; C R Popescu; D C Gheorghe
Journal:  J Med Life       Date:  2014-09-25

Review 8.  Melatonin Therapy in Patients with Alzheimer's Disease.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Luis I Brusco
Journal:  Antioxidants (Basel)       Date:  2014-04-10

9.  Melatonin promotes triacylglycerol accumulation via MT2 receptor during differentiation in bovine intramuscular preadipocytes.

Authors:  Wucai Yang; Keqiong Tang; Yaning Wang; Yingying Zhang; Linsen Zan
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

Review 10.  The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

Authors:  Domenico De Berardis; Stefano Marini; Michele Fornaro; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Alessandro Valchera; Giampaolo Perna; Maria-Antonia Quera-Salva; Giovanni Martinotti; Massimo di Giannantonio
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.